According to China's clinical trials of COVID-19 treatment, the most clinically tested varieties are chemical drugs, especially chloroquine and antiviral drugs. Due to effective control, the proportion of clinical trials in China has been greatly reduced. Among the chemical drug clinical projects, chloroquine accounted for the largest proportion, followed by ritonavir?lopinavir and ridacive.
This report focuses on the investigation and analysis of chemical medication in COVID-19 and predicts the future market development of biopharmaceuticals under the influence of COVID-19.
This report aims to provide a comprehensive presentation of the global market for Chemical Medication in COVID-19, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Chemical Medication in COVID-19. This report contains market size and forecasts of Chemical Medication in COVID-19 in global, including the following market information:
Global Chemical Medication in COVID-19 Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Chemical Medication in COVID-19 market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Remedsivir Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Chemical Medication in COVID-19 include Gilead Sciences, AbbVie, Johnson & Johnson, Pfizer, Mylan, Bayer, Zhejiang Hisun, CSPC Pharmaceutical Group and Reyoung Pharmaceutical, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Chemical Medication in COVID-19 companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Chemical Medication in COVID-19 Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Chemical Medication in COVID-19 Market Segment Percentages, by Type, 2022 (%)
- Remedsivir
- Ardidol
- Favipivir
- Lopinavir/ritonavir (LPV/r)
- Chloroquine
- Others
Global Chemical Medication in COVID-19 Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Chemical Medication in COVID-19 Market Segment Percentages, by Application, 2022 (%)
- COVID-19
- Influenza
- Malaria
- Others
Global Chemical Medication in COVID-19 Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Chemical Medication in COVID-19 Market Segment Percentages, By Region and Country, 2022 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Chemical Medication in COVID-19 revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Chemical Medication in COVID-19 revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Gilead Sciences
- AbbVie
- Johnson & Johnson
- Pfizer
- Mylan
- Bayer
- Zhejiang Hisun
- CSPC Pharmaceutical Group
- Reyoung Pharmaceutical
- Sihuan Pharmaceutical
- Hikma Pharmaceuticals
- Rising Pharmaceutical
- Sun Pharma
- Shanghai Pharma
- Guangzhou Baiyunshan Guanghua Pharmaceutical
- KPC Group
- Jinghua Pharmaceutical Group
- Zhongsheng Pharma
- North China Pharmaceutical Group
Outline of Major Chapters:
Chapter 1: Introduces the definition of Chemical Medication in COVID-19, market overview.
Chapter 2: Global Chemical Medication in COVID-19 market size in revenue.
Chapter 3: Detailed analysis of Chemical Medication in COVID-19 company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Chemical Medication in COVID-19 in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
